All > Acupressure > Soft Tissue Sarcoma

Archival tumor tissue collection and blood draws for Soft Tissue Sarcoma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Soft Tissue SarcomaArchival tumor tissue collection and blood draws - Procedure
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will collect blood and tumor tissue samples to study circulating tumor DNA, which may be useful for cancer detection, predicting treatment response, and disease monitoring.

Eligible Conditions
  • Soft Tissue Sarcoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Tumour tissue collection
1
Gemcitabine
1
Pembrolizumab

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 years

5 years
Number of patients with demonstrable circulating tumor DNA (ctDNA) quantification
Number of patients with demonstrable ctDNA quantification with no pre-op tumor burden, necrosis at surgery, or disease recurrence

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Tumour tissue collection
1
Gemcitabine
1
Pembrolizumab

Trial Design

1 Treatment Group

Soft Tissue Sarcoma
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Archival tumor tissue collection and blood draws · No Placebo Group · N/A

Soft Tissue Sarcoma
Procedure
Experimental Group · 1 Intervention: Archival tumor tissue collection and blood draws · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,382 Previous Clinical Trials
473,435 Total Patients Enrolled
Mount Sinai Hospital, CanadaOTHER
183 Previous Clinical Trials
64,074 Total Patients Enrolled
The Hospital for Sick ChildrenOTHER
642 Previous Clinical Trials
6,816,479 Total Patients Enrolled
Albiruni Razak, M.D.Principal InvestigatorPrincess Margaret Cancer Centre
3 Previous Clinical Trials
111 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are able to understand and willing to sign a written informed consent document and comply with study requirements.
You must be between the ages of 18 and 65 years old.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top